Abbott

Tin tức

Reuters - 26 phút trước

FTSE 100 rebounds on Reckitt boost but logs weekly decline

UPDATE 1-FTSE 100 rebounds on Reckitt boost but logs weekly decline FTSE 100 up 0.8%, FTSE 250 up 0.5% Reckitt up after clearance in preterm formula case Focus on U.S. election next week BoE rate decision on Nov. 7 Updated at 1632 GMT By Sruthi Shankar and Nikhil Sharma Nov 1 (Reuters) - The UK's FTSE 100 rebounded on Friday from near three-month lows touched in the prior session, as gains in Reckitt Benckiser helped offset concerns about inflation sparked by the first Labour government budget i

Reuters - 4 giờ trước

U.S. STOCKS Wayfair, B. Riley, Church & Dwight

BUZZ-U.S. STOCKS ON THE MOVE-Wayfair, B. Riley, Church & Dwight Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stock futures rose on Friday, buoyed by strong Amazon results offsetting the previous session's tech selloff, with investors awaiting nonfarm payrolls data for insights on the Federal Reserve's key policy rate trajectory.

Reuters - 5 giờ trước

U.S. STOCKS Intel, Abbott, Boeing

BUZZ-U.S. STOCKS ON THE MOVE-Intel, Abbott, Boeing Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stock index futures slightly pared gains on Friday after job additions in October were much lower than estimated, while the unemployment rate remained steady.

Reuters - 6 giờ trước

Abbott shares rise after securing first win in premature infant formula trial

Abbott shares rise after securing first win in premature infant formula trial Nov 1 (Reuters) - Abbott Laboratories ABT.N shares rose nearly 5% before the bell on Friday, after a jury cleared the company and a Reckitt unit of liability in a lawsuit over their premature baby formulas' risks. A jury in St. Louis, Missouri found on Thursday that Abbott and Reckitt RKT.L unit Mead Johnson are not responsible for a young boy's severe intestinal disease, marking the first victory for the companies aft

Reuters - 7 giờ trước

FTSE 100 rebounds as Reckitt and oil stocks offset budget concerns

FTSE 100 rebounds as Reckitt and oil stocks offset budget concerns For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window FTSE 100 up 0.6%, FTSE 250 0.2% Oct 28 (Reuters) - The UK's FTSE 100 edged up on Friday from near three-month lows touched in the prior session, as gains in Reckitt Benckiser and oil stocks offset concerns about inflation sparked by Britain's budget.

Reuters - 7 giờ trước

Abbott climbs on being cleared of liability in latest preterm formula case

BUZZ-Abbott climbs on being cleared of liability in latest preterm formula case ** Shares of medical device maker Abbott Laboratories ABT.N rise ~5% to $118.94 premarket ** Abbott and British consumer goods company Reckitt's RKT.L unit Mead Johnson cleared of liability in a preterm formula case, accusing them of failing to warn about the risks of t

Reuters - 8 giờ trước

Europe's STOXX 600 jumps 1% as banks lead market rebound, US election in focus

UPDATE 2-Europe's STOXX 600 jumps 1% as banks lead market rebound, US election in focus For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window Banks top weekly gainer Reckitt jumps after being cleared in preterm formula case Maersk, Technip Energies rise for second day on outlook boost Fugro slumps after it reports lower revenue in US, Middle East Updates with closing levels By Ankika Biswas and Pranav Kashyap Nov 1 (Reuters) - Europe's main st

Reuters - 9 giờ trước

Reckitt jumps after being cleared in preterm formula case

BUZZ-Reckitt jumps after being cleared in preterm formula case ** Shares in British consumer goods company Reckitt RKT.L surge 11.1% to 5,204 pence, top gainers on the FTSE bluechip index .FTSE ** Abbott ABT.N and Reckitt's RKT.L unit Mead Johnson were cleared of liability in a preterm formula case on Thursday ** Lawsuit had accused the companies f

Reuters - 10 giờ trước

UK Stocks-Factors to watch on Nov 1

UPDATE 1-UK Stocks-Factors to watch on Nov 1 Adds new items, updates futures Nov 1 (Reuters) - Britain's FTSE 100 .FTSE index is seen opening flat on Friday, with futures FFIc1 up 0 .02%. * BOOHOO: British online fashion retailer Boohoo BOOH.L appointed Dan Finley as its new CEO , effective immediately, to succeed John Lyttle, a week after top investor Frasers FRAS.L wanted its controlling shareholder Mike Ashley in the role.

Reuters - 12 giờ trước

UK Stocks-Factors to watch on Nov 1

UK Stocks-Factors to watch on Nov 1 Nov 1 (Reuters) - Britain's FTSE 100 .FTSE index is seen opening higher on Friday, with futures FFIc1 up 0.14%. * UK BONDS: British government bond prices tumbled for a second day on Thursday as investors judged finance minister Rachel Reeves' first budget would boost inflation and cause the Bank of England to cut interest rates more slowly.

Reuters - 19 giờ trước

Abbott rises after being cleared of liability in preterm formula case

BUZZ-Abbott rises after being cleared of liability in preterm formula case ** Shares of medical device maker Abbott Laboratories ABT.N rise 5.4% to $119.5 in after-hours trading ** ABT and Reckitt RKT.L unit Mead Johnson are not responsible for a young boy's debilitating intestinal disease, jury finds ** Lawsuit accused ABT and RKT of failing to wa

Reuters - 20 giờ trước

Abbott and Reckitt unit secure win in infant formula trial

UPDATE 3-Abbott and Reckitt unit secure win in infant formula trial Verdict is victory for the companies after large losses in similar lawsuits Reckitt shares jump 10% after the verdict Plaintiff's lawyers sought award of over $6.2 billion Abbott says proves preterm formulas are safe Updates shares, adds analyst comment in paragraph 12 By Brendan Pierson Nov 1 (Reuters) - Abbott ABT.N and Reckitt's RKT.L unit Mead Johnson are not responsible for a young boy's debilitating intestinal disease, a j

Reuters - 21 giờ trước

Abbott, Reckitt cleared of liability in latest preterm formula case

Abbott, Reckitt cleared of liability in latest preterm formula case By Brendan Pierson Oct 31 (Reuters) - Abbott ABT.N and Reckitt RKT.L unit Mead Johnson are not responsible for a young boy's debilitating intestinal disease, a jury found on Thursday in a lawsuit accusing them of failing to warn of their premature baby formulas' risks, a victory for the two companies following large losses in similar trials.

Reuters - 2 ngày trước

Jury asked to award more than $6 billion in preterm formula case against Abbott, Reckitt's Mead

UPDATE 1-Jury asked to award more than $6 billion in preterm formula case against Abbott, Reckitt's Mead Adds material from defense closings in paragraphs 6-8 By Brendan Pierson Oct 30 (Reuters) - A lawyer for a Missouri mother on Wednesday asked a jury to make Abbott ABT.N and Reckitt's RKT.L Mead Johnson pay a total of more than $6 billion in the latest trial over claims that the companies' formulas for premature babies caused a severe intestinal illness.

Reuters - 2 ngày trước

Jury asked to award more than $6 billion in preterm formula case against Abbott, Reckitt's Mead

Jury asked to award more than $6 billion in preterm formula case against Abbott, Reckitt's Mead By Brendan Pierson Oct 30 (Reuters) - A lawyer for a Missouri mother on Wednesday asked a jury to make Abbott ABT.N and Reckitt's RKT.L Mead Johnson pay a total of more than $6 billion in the latest trial over claims that the companies' formulas for premature babies caused a severe intestinal illness.

Reuters - 3 ngày trước

India's GlaxoSmithKline Pharma posts higher Q2 profit on strong demand

India's GlaxoSmithKline Pharma posts higher Q2 profit on strong demand Oct 29 (Reuters) - India's GlaxoSmithKline Pharmaceuticals GLAX.NS reported a higher second-quarter adjusted profit on Tuesday, driven by strong demand for its generic drugs and vaccines. The Indian unit of British drugmaker GSK GSK.L said its consolidated profit before tax rose to 3.44 billion rupees ($41 million) in the July-September quarter, from 2.99 billion rupees year ago.

Reuters - 1 tuần trước

Edwards forecast fourth-quarter sales below expectations on soft demand for heart devices

Edwards forecast fourth-quarter sales below expectations on soft demand for heart devices Oct 24 (Reuters) - Edwards Lifesciences EW.N on Thursday forecast fourth-quarter sales below Wall Street estimates , hurt by softer demand and fierce competition for its artificial heart valves . Investor expectations for medical device makers have risen in recent quarters as demand for surgical procedures, especially among older adults, remains high.

Reuters - 1 tuần trước

Formula makers cannot use US government statement in trial over preterm baby illness

Formula makers cannot use US government statement in trial over preterm baby illness By Brendan Pierson Oct 23 (Reuters) - Abbott ABT.N and Reckitt's RKT.L Mead Johnson will not be allowed to show jurors a statement by U.S. government agencies and a government-commissioned report to defend themselves against a lawsuit by a mother who says her son got a severe intestinal illness from the companies' baby formula for premature infants.

Reuters - 1 tuần trước

Boston Scientific lifts annual profit forecast on strong demand for heart devices

Boston Scientific lifts annual profit forecast on strong demand for heart devices Oct 23 (Reuters) - Boston Scientific BSX.N raised its annual profit forecast and exceeded Wall Street's estimates for third-quarter profit on Wednesday, driven by robust demand for its heart devices, sending its shares higher 1.1% to $88.94 in premarket trading. Medical device makers have been benefiting from elevated demand for non-urgent surgeries in recent quarters, as Americans, especially the elderly, catch up

Reuters - 2 tuần trước

Intuitive beats quarterly profit estimates on strong demand for surgical robots

UPDATE 1-Intuitive beats quarterly profit estimates on strong demand for surgical robots Adds outlook in paragraph 6, company comments in paragraph 7, background in paragraphs 8-9 By Mariam Sunny Oct 17 (Reuters) - Medical device maker Intuitive Surgical ISRG.O beat Wall Street estimates for third-quarter profit on Thursday, helped by strong demand for its surgical robots used in minimally invasive procedures, sending shares up 6% in extended trading.

Các điều kiện

Các tài sản phổ thông

Khước từ trách nhiệm: các tổ chức thuộc XM Group chỉ cung cấp dịch vụ khớp lệnh và truy cập Trang Giao dịch trực tuyến của chúng tôi, cho phép xem và/hoặc sử dụng nội dung có trên trang này hoặc thông qua trang này, mà hoàn toàn không có mục đích thay đổi hoặc mở rộng. Việc truy cập và sử dụng như trên luôn phụ thuộc vào: (i) Các Điều kiện và Điều khoản; (ii) Các Thông báo Rủi ro; và (iii) Khước từ trách nhiệm toàn bộ. Các nội dung như vậy sẽ chỉ được cung cấp dưới dạng thông tin chung. Đặc biệt, xin lưu ý rằng các thông tin trên Trang Giao dịch trực tuyến của chúng tôi không phải là sự xúi giục, mời chào để tham gia bất cứ giao dịch nào trên các thị trường tài chính. Giao dịch các thị trường tài chính có rủi ro cao đối với vốn đầu tư của bạn.

Tất cả các tài liệu trên Trang Giao dịch trực tuyến của chúng tôi chỉ nhằm các mục đích đào tạo/cung cấp thông tin và không bao gồm - và không được coi là bao gồm - các tư vấn tài chính, đầu tư, thuế, hoặc giao dịch, hoặc là một dữ liệu về giá giao dịch của chúng tôi, hoặc là một lời chào mời, hoặc là một sự xúi giục giao dịch các sản phẩm tài chính hoặc các chương trình khuyến mãi tài chính không tự nguyện.

Tất cả nội dung của bên thứ ba, cũng như nội dung của XM như các ý kiến, tin tức, nghiên cứu, phân tích, giá cả, các thông tin khác hoặc các đường dẫn đến trang web của các bên thứ ba có trên trang web này được cung cấp với dạng "nguyên trạng", là các bình luận chung về thị trường và không phải là các tư vấn đầu tư. Với việc các nội dung đều được xây dựng với mục đích nghiên cứu đầu tư, bạn cần lưu ý và hiểu rằng các nội dung này không nhằm mục đích và không được biên soạn để tuân thủ các yêu cầu pháp lý đối với việc quảng bá nghiên cứu đầu tư này và vì vậy, được coi như là một tài liệu tiếp thị. Hãy chắc chắn rằng bạn đã đọc và hiểu Thông báo về Nghiên cứu Đầu tư không độc lập và Cảnh báo Rủi ro tại đây liên quan đến các thông tin ở trên.

Abbott

Tin tức

Các điều kiện

Các tài sản phổ thông

Chat trực tiếp XM